Nature of the Event

Aster DM Healthcare Limited has acquired 3,57,143 Optionally Convertible Redeemable Preference Shares (OCRPS) in Alfaone Medicals Private Limited, an associate company, through a rights issue. The acquisition was made on June 29, 2026, and is disclosed pursuant to Regulation 30 of the SEBI Listing Regulations.

Key Quantitative Figures

  • Number of shares acquired: 3,57,143 OCRPS
  • Face value per share: ₹10
  • Acquisition price per share: ₹700 (including security premium of ₹690)
  • Total consideration: ₹25,00,00,100 (Twenty-Five Crore and One Hundred Rupees Only)
  • Alfaone Medicals' turnover for FY ended March 31, 2026: ₹589.55 lakhs
  • Authorized Share Capital of Alfaone: ₹6,36,94,690
  • Paid-up Share Capital of Alfaone: ₹5,75,00,410

Dates of Action

The acquisition and allotment of shares occurred on June 29, 2026. The disclosure was made on the same date.

Parties Involved

  • Acquiring Company: Aster DM Healthcare Limited
  • Target Entity: Alfaone Medicals Private Limited (AMPL), an associate company
  • Regulatory References: SEBI Listing Regulations Regulation 30, SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026

Purpose or Rationale

The investment by Aster DM Healthcare is being made for general corporate purposes of Alfaone Medicals Private Limited.

Related Party Transaction Status

The transaction falls within the ambit of related party transactions as AMPL is an associate company of Aster DM Healthcare. The Board has approved the related party transaction, and it was conducted on an arm's length basis. Apart from this, the promoter/promoter group/group companies do not have any interest in AMPL.

Shareholding Impact

Pre-Acquisition Holding:

  • Equity Shares: 11,50,941 shares (48.91%)
  • OCRPS: 33,97,100 shares (100%)

Post-Acquisition Holding:

  • Equity Shares: 11,50,941 shares (48.91%) - unchanged
  • OCRPS: 37,54,243 shares (100%)

Company Background

Alfaone Medicals Private Limited was incorporated on December 03, 2020, in Bengaluru, Karnataka, India, to carry on the business of trading drugs and pharmaceuticals. The company operates in the healthcare industry.

Additional Information

No governmental or regulatory approvals were required for this acquisition. The consideration was paid in cash. The information will be available on the company's website at https://www.asterdmhealthcare.in.

#Tags: #AsterDMHealthcare #AlfaoneMedicals #SEBIRegulation30 #RelatedPartyTransaction #InvestmentDisclosure